This is what analysts have to say about Histogenics Corporation (NASDAQ:HSGX) after last week. MoneyMakingArticles
Among 2 analysts covering Histogenics (NASDAQ:HSGX), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Histogenics had 2 analyst reports since …